Assessment of Cognitive Functions in Bipolar Patients
- Conditions
- Bipolar Disorder
- Registration Number
- NCT04091828
- Lead Sponsor
- Assiut University
- Brief Summary
Assessment of cognitive function in manic bipolar patient
- Detailed Description
Assessment of severity of mania and depression in bipolar patients then evaluate their cognitive function.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
- Aged 18-55 years
- Of both sex
- Diagnosed as bipolar by DSM-5(patient)
Exclusion Criteria
- Current medical and psychiatric comorbidities which may affect cognitive status.
- Substance abuse or dependence (except nicotine and caffeine)in last month.
- Somatic treatment with drugs known to affect cognitive status (cortisol, antihistamines, etc.)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of severity of mania in bbipolar patients 2019-2022 EVALUATE manic patients by Young Mania Rating Scale (YMRS)
Assessment of severity of depression in bipoiar patients 2019-2022 Evaluate depressed patients by Hamilton Rating Scale for depression(HRS).
Assessment of cognitive function in bipoiar patients 2019-2022 Evaluate cognition in included patients by Montreal Cognitive Assessment(MOCA) and P300.
- Secondary Outcome Measures
Name Time Method Correlation between cognitive state in bipolar patient and(onset age,illness duration and number of episodes). 2019-2021 from history
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link dopamine dysregulation to cognitive deficits in Bipolar I vs. Bipolar II patients?
How do inflammatory biomarkers correlate with cognitive impairment severity in manic bipolar disorder?
What are the comparative cognitive outcomes between lithium-treated and antipsychotic-treated bipolar patients?
Which neurocognitive domains are most affected during mixed episodes in bipolar disorder observational studies?
How does mTOR signaling pathway modulation relate to cognitive function assessment in bipolar disorder research?